How is a pacemaker replaced and what happens to the old one?
A pacemaker replacement is usually just a battery swap that reuses the existing leads, and it is generally low-risk with same-day discharge possible for some patients.
Covers: Why pacemaker generators are replaced, how the procedure is performed (including whether leads are reused or replaced), recovery, and what is done with the removed device. Does not cover initial pacemaker implantation or the management of pacemaker infections.
Also answers: How does a pacemaker get replaced and what happens to the old one? · What happens during pacemaker replacement surgery? · Do they remove the old pacemaker when replacing it? · Pacemaker battery replacement procedure
- One page for this question6 other ways of asking lead here
- 6 independent sourcesEvery claim links to what supports it
- 3 connected pages3 changed this week
- Clean discussionScreened before anything appears
The short answer
Interpretation AI-prepared starting mapA pacemaker replacement is usually a generator (battery) change: the pulse generator in the chest pocket is swapped while the existing leads are left in place and reconnected. It is a common, generally low-risk procedure — in one UK cohort of 510 replacement patients, 25% had heart-failure hospitalisation or death over a median 30 months, but this was largely driven by comorbidities rather than pacing burden. Procedure times are short (median 21–22 minutes in one study; mean 16.9 minutes for leadless implants in very elderly patients). Complications are uncommon but real: in a registry of 222 advisory-related replacements, 4.1% had major complications (mostly lead damage or pocket problems) and 4.1% had minor ones (mostly conservatively managed haematoma). Same-day discharge is feasible in selected patients, with comparable complication rates to overnight stay (2.1% vs 1.1%) and a median hospital stay of 0 vs 2 days.1234
- Evidence 17
- Interpretation 3
Did this answer your question?
Be the first to voteIn brief
Complications are uncommon but not negligible: 4.1% major and 4.1% minor in an advisory-replacement registry, mostly lead damage, haematoma, or pocket problems.2
Evidence-backedSame-day discharge is feasible and safe in carefully selected patients, with comparable short- and mid-term outcomes and a median 0 vs 2 days in hospital.3
Evidence-backedLead extraction is a separate, more complex procedure reserved for infection, lead damage, upgrades, occluded veins, or vascular overload — not part of routine replacement.5
Evidence-backedFor very elderly patients at high infection risk, leadless pacing is an alternative to conventional replacement, with 2.8% complications in a 71-patient series and no infections.4
Evidence-backed
At a glance
The picture in numbers
Live · updated just now
22 minutes
- Major complications4.1%
- Minor complications4.1%
- Same-day discharge2.1%
- Overnight stay1.1%
- Same-day discharge0 days
- Overnight stay2 days
The evidence behind it
7 sources- Other studies and data7
When it was published
Newest from 2026
| Source | Kind | Year |
|---|---|---|
| Prevalence and incidence of left ventricular systolic dysfunction and adverse outcomes in patients receiving de novo and replacement pacemaker therapy for bradycardia. | Other studies and data | 2026 |
| Leadless pacemaker implantation as an alternative to generator replacement in very elderly patients | Other studies and data | 2026 |
| Complications Associated with Generator Replacement in Response to Device Advisories | Other studies and data | 2007 |
| Comparaison of conventional vs same day discharge for pacemaker replacements: the START study | Other studies and data | 2026 |
| Making the cut for generator replacements | Other studies and data | 2021 |
| Preventing complications in cardiac pacemaker therapy: a lifecycle-based risk management framework. | Other studies and data | 2026 |
| Pacemaker and defibrillator lead extraction | Other studies and data | 2003 |
The community around it
No one has added to this page yet. Firsthand experience, a newer study or a different reading of the numbers would show up here, credited to you.
What it means for you
Which fits you?
Pick the situation closest to yours. Each answer says what it rests on.
If you are otherwise healthy and your replacement is a routine battery change
expect a short procedure (around 20 minutes) with the existing leads reused, and ask whether you are eligible for same-day discharge under a standardised protocol.3
Evidence-backedIf you are very elderly or at high risk of device infection
leadless pacemaker implantation may be worth discussing as an alternative to conventional generator replacement; in a 71-patient series it had a 2.8% complication rate and no infections.4
Evidence-backedIf your replacement is prompted by a device advisory or recall
treat it as a procedure with real, if uncommon, risks — 4.1% major complications in one registry — and ask for an individual risk assessment rather than assuming it is risk-free.2
Evidence-backedIf you have multiple leads, an occluded vein, or are being upgraded to a defibrillator or biventricular device
ask whether lead extraction will be needed, since extraction is a distinct and more complex procedure than a simple generator change.5
Evidence-backedIf you have heart failure risk factors such as diabetes or ischaemic heart disease
ask about left-ventricular function assessment and follow-up, since left-ventricular systolic dysfunction is common in pacemaker recipients and largely driven by comorbidities.1
Evidence-backedIf you want to reduce time in hospital
ask whether your centre offers a same-day discharge pathway, which in one study cut median stay from 2 days to 0 without a significant difference in complications or 6-month rehospitalisation.3
Evidence-backedThe full story · 4 chapters
01
Why generators are replaced
AI summary:Generators are replaced when the battery runs low or a device is under advisory, and replacement patients carry their own risk profile.
Evidence-backed: Pacemaker generators are replaced when the battery nears the end of its service life, or when a device is subject to a manufacturer advisory or recall. In a registry of 1,039 patients with advisory devices, 222 (21.4%) underwent replacement. Replacement is not a trivial event: in a prospective UK cohort, patients undergoing generator replacement were more likely to have atrial fibrillation (33% vs 25%) and less likely to have ischaemic heart disease (14% vs 31%) or diabetes (6% vs 24%) than patients receiving a first (de novo) right-ventricular pacemaker, and over a median 30 months 25% of replacement patients versus 8% of de novo patients experienced heart-failure hospitalisation or death. The authors attribute left-ventricular systolic dysfunction largely to comorbidities rather than pacing burden.21
Interpretation: A lifecycle-based review argues that complication risk varies across the phases of device therapy and that prevention should extend beyond the operating room to structured pre-procedural assessment, standardised intra-operative technique, and long-term surveillance. This framing is useful for thinking about replacement as a planned procedure with its own risk profile rather than a routine repeat of implantation.6
02
How the procedure is performed
AI summary:The generator is swapped and existing leads reused, with short procedure times and lead damage as the main hazard.
Evidence-backed: In a conventional replacement, the generator in the chest pocket is exchanged and the existing leads are reused. Procedure times are short: median 22 minutes for conventional admission and 21 minutes for same-day discharge in one study, and mean 16.9 minutes for leadless pacemaker implantation in a very elderly cohort. The main technical hazard is damage to the leads during pocket re-entry and reconnection. In the advisory-replacement registry, four atrial leads were damaged (two repaired, one during the same procedure and one later), one patient needed reoperation to tighten a loose ventricular lead set screw, and two needed pocket revision for severe discomfort from device positioning.342
Evidence-backed: Leads are not routinely extracted at replacement. Extraction becomes relevant when leads are infected, damaged, or when a system is upgraded (for example pacemaker to defibrillator or biventricular device), when vasculature is occluded and a conduit is needed for reimplantation, or when vascular overload from multiple leads requires removal. Extraction is a distinct, more complex procedure: leads have grown more complex, powered sheaths (laser and electrocautery) have been developed to speed removal, and complication rates remain low but constant as more leads are extracted.5
Evidence-backed: For very elderly patients at high risk of infection, leadless pacemaker implantation has been proposed as an alternative to conventional generator replacement. In a series of 71 patients (mean age 89.6 years, 94% with dementia), procedure time averaged 16.9 minutes, paced QRS duration was essentially unchanged (155.7 ms before vs 154.5 ms after), complications occurred in 2 patients (2.8%: one cardiac tamponade treated by pericardiocentesis, one threshold elevation requiring reimplantation), and there were no infections or major vascular complications. Mean hospital stay was 3.1 days, described as shorter than conventional generator replacement.4
03
Recovery and discharge
AI summary:Same-day discharge is feasible in selected patients, and complications are mostly local and manageable.
Evidence-backed: Same-day discharge after replacement has been tested in a study comparing conventional admission (group A) with same-day discharge (group H) under standardised protocols. Procedure duration was similar (median 22 vs 21 minutes), complication rates were low and comparable (2.1% vs 1.1%), hospitalisation was prolonged in 5.9% vs 3.8% (mostly for non-medical reasons), and reintervention or rehospitalisation at 6 months did not differ significantly (2.1% vs 2.7%). Total hospital stay was substantially shorter with same-day discharge (median 0 vs 2 days). The authors conclude same-day discharge is feasible and safe in carefully selected patients.3
Evidence-backed: Complications after replacement are mostly local and manageable. In the advisory registry, minor complications were haematoma managed conservatively (6 patients), local discomfort (1), and incisional infection treated with oral antibiotics (2); major complications (4.1%) included lead damage, a loose set screw requiring reoperation, haematoma requiring evacuation, pocket revision for discomfort, and one preoperative cerebrovascular accident. There were no perioperative deaths and no infections requiring system removal. The authors stress that complications can occur even with experienced operators and that individual risk assessment matters.2
04
What happens to the old pacemaker
AI summary:The sources do not say what happens to the explanted generator, leaving a genuine gap.
Interpretation: The sources describe the removal of the generator from the pocket and the handling of leads, but none states what is done with the explanted generator itself — whether it is discarded as clinical waste, returned to the manufacturer, or sent for analysis. This is a genuine gap in the available evidence rather than a point on which sources disagree.25
Your turn
Have your say
See where others stand. Join free to add your perspective. One answer per account.
How do you feel about this?
No votes yetQuick questions from connected pages
Before you go
What to remember
Try to recall each hidden figure before you reveal it. Remembering, not rereading, is what makes it stick.
Replacement is usually a generator swap: the battery is exchanged and existing leads are reused, with median procedure times around minutes.
Complications are uncommon but not negligible: major and 4.1% minor in an advisory-replacement registry, mostly lead damage, haematoma, or pocket problems.
Same-day discharge is feasible and safe in carefully selected patients, with comparable short- and mid-term outcomes and a median vs 2 days in hospital.
Your reading
0 of 4 chaptersThis answer keeps changing
When new evidence or a better source comes in, this page is updated (it's on version 2, last changed 1 hour ago). Follow it to be told when that happens.
Up nextHow is a pacemaker replaced?How does a pacemaker get replaced and what happens during the procedure?Ask this Sylo
Still wondering about something?
Answers come only from this page's reviewed material, with citations, and say plainly when the page doesn't cover it yet.
Behind this page
Who's adding to it, where it comes from, how it changed and what would make it better. Always open to everyone.
Discussion
Sources
Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.
- 1Prevalence and incidence of left ventricular systolic dysfunction and adverse outcomes in patients receiving de novo and replacement pacemaker therapy for bradycardia.European heart journal open (Abdul et al.)Published Apr 27, 2026Checked Oct 12, 2026
“We investigated the prevalence and predictors of LVSD and adverse HF outcomes in patients undergoing de novo or replacement RVP for bradycardia.Methods and resultsProspective data were collected from 1024 patients receiving de novo (2014-2017, n = 514) or generator replacement (2008-2011, n = 510) RVP at a UK tertiary centre. Logistic regression models were used to identify predictors of LVSD, defined as left ventricular ejection fraction (LVEF) De novo patients were more often male (66% vs. 56%) and more likely to have ischaemic heart disease (IHD; 31% vs. 14%) and diabetes (24% vs. 6%), but less likely to have atrial fibrillation (AF; 25% vs. 33%) than replacement patients (all P de novo than replacement cases (20% vs. 17%, P 80% (OR = 2.13, CI: 1.29-3.52). Over a median 30 (IQR: 16-42) months, 341 (33%) experienced HFH or death, more commonly after replacement than de novo RVP (25% vs. 8%, P ConclusionLVSD is common in RVP recipients and largely driven by comorbidities rather than pacing burden. Screening and targeted therapy in high-risk patients may improve outcomes and optimize resource use.”
- 2Complications Associated with Generator Replacement in Response to Device AdvisoriesJournal of Cardiovascular Electrophysiology (Costea et al.)Published Dec 13, 2007Checked Oct 12, 2026
“Two hundred and twenty-two of 1,039 (Medtronic 273, Guidant 766) (21.4%) patients with advisory devices underwent device replacement. Nine minor complications occurred: hematoma managed conservatively (n = 6); local discomfort (n = 1); and incisional infections treated successfully with oral antibiotics (n = 2). Major complications occurred in nine patients (4.1%). Four atrial leads were damaged, two of which were repaired, one during the same procedure and the other at a later date. One patient required a reoperation to tighten a loose ventricular lead set screw. Hematoma requiring evacuation occurred in one patient, and pocket revision was necessary in two patients secondary to severe discomfort due to the positioning of the device in the pocket. One patient had a cerebrovascular accident preoperatively. There were no perioperative deaths or infections requiring system removal. Even with experienced operators complications can occur when replacing generators for a device recall. Careful risk assessment for each individual patient should be performed and efforts made to minimize generator changes.”
- 3Comparaison of conventional vs same day discharge for pacemaker replacements: the START studyEP Europace (Probst et al.)Published Jun 1, 2026Checked Oct 12, 2026
“Baseline characteristics were similar between the two groups. The two groups showed a comparable profile regarding pacemaker type, indication, and implantation history. The median procedure duration was 22 minutes in A versus 21 minutes in H (p = 0.84). Complication rates were low and comparable: 2.1% in A versus 1.1% in H (p = 0.69). The rate of hospitalization prolongation was 5.9% in A versus 3.8% in H (p = 0.34). The reasons for prolonged hospitalization were mostly non-medical. No significant difference was observed in reintervention or rehospitalization at 6 months (2.1% vs 2.7%, p = 0.75). Total hospitalization duration was significantly reduced in the A group (median = 0 days vs 2 days; p < 0.001). Pacemaker replacement with same-day discharge is feasible and safe in carefully selected patients. When performed under standardized protocols, this strategy ensures similar short- and mid-term outcomes compared to conventional hospitalization, while substantially reducing hospital stay and resource utilization. These results support the integration of SDD programs into routine clinical practice for device replacement.”
- 4Leadless pacemaker implantation as an alternative to generator replacement in very elderly patientsEP Europace (Misonou et al.)Published Jun 1, 2026Checked Oct 12, 2026
“The mean age was 89.6±6.9 years, with 48 females (67.6%) and a mean body mass index of 19.7±3.3 kg/m2. Comorbidities included dialysis in 4 (5.6%), chronic obstructive pulmonary disease in 14 (19.7%), and dementia in 67 (94%). Indications were sick sinus syndrome in 11 (15.5%), bradycardic atrial fibrillation in 27 (38.0%), and atrioventricular block in 33 (46.5%). Devices used were Micra™ in 61 patients and Aveir™ in 10. Mean procedure time was 16.9±6.6 minutes. Paced QRS duration remained essentially unchanged, from 155.7±24.1 ms before LP implantation to 154.5±18.2 ms afterward. Complications occurred in 2 patients (2.8%): one cardiac tamponade managed by pericardiocentesis and one threshold elevation requiring re-implantation. No infections or major vascular complications were observed. Mean hospital stay following implantation was 3.1±1.8 days. Leadless pacemaker implantation is a safe and effective alternative to generator replacement in very elderly patients at high risk of infection, while ensuring favorable procedural and clinical outcomes. Furthermore, LP implantation was associated with a shorter time to discharge compared with conventional generator replacement.”
- 5Pacemaker and defibrillator lead extractionCurrent Opinion in Cardiology (Kutalek)Published Dec 22, 2003Checked Oct 12, 2026
“Further, leads have become more complex, particularly for defibrillator systems, resulting in the development of powered extraction sheaths to expedite their removal. For these reasons, it is important to understand the expanding indications, procedural aspects, and limitations of arrhythmia device extraction. RECENT FINDINGS: Expanded indications for lead extraction include upgrade to more complex systems, particularly pacemaker to defibrillator or biventricular device, extraction through occluded vasculature to produce a conduit for reimplantation, more frequent removal due to vascular overload with multiple leads, and a finite frequency of infection, occurring particularly with device replacement or revision. Powered sheaths now include laser and electrocautery systems, both improving the ease of lead explantation. SUMMARY: Complication rates remain low but constant with extraction of larger numbers of leads using new technologies. Expansion of the use of biventricular systems, with implantation of coronary sinus electrodes, will continue to challenge lead extraction in terms of technology and safety. Design of leads that are easier to remove remains of paramount importance.”
- 6Preventing complications in cardiac pacemaker therapy: a lifecycle-based risk management framework.Frontiers in cardiovascular medicine (Li et al.)Published Jun 1, 2026Checked Oct 12, 2026
“These events may arise from procedural factors, lead or device dysfunction, device-associated infection, or subsequent structural and functional alterations of the heart. This review proposes a structured lifecycle-based risk management framework that integrates complication prevention across the entire continuum of pacemaker therapy. This approach highlights the dynamic nature of complication risk across different phases of device therapy. Within this lifecycle risk-management paradigm, complication prevention should extend beyond isolated perioperative measures and encompass structured preprocedural assessments, standardized intraoperative techniques, and longitudinal postprocedural surveillance. By synthesizing current evidence regarding the underlying mechanisms and clinical manifestations of pacemaker-related complications and contemporary prevention and management strategies for these complications, this work provides a comprehensive overview. This framework-based approach offers a practical strategy to enhance risk stratification, guide procedural decision-making, and improve long-term outcomes in patients undergoing pacemaker therapy.”
- 7Making the cut for generator replacementsJournal of Cardiovascular Electrophysiology (Ravi & Wasserlauf)Published Feb 24, 2021Checked Oct 12, 2026
“Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58:1001-1006.2. Poole JE, Gleva MJ, Mela T, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.Circulation. 2010;122:1553-1561.3. Kypta A, Blessberger H, Saleh K, et al. An electrical plasma surgery tool for device replacement–retrospective evaluation of complications and economic evaluation of costs and resource use. Pacing Clin Electrophysiol. 2015;38:28-34.4. Wasserlauf J, Esheim T, Jarett NM, et al. Avoiding damage to transvenous leads-A comparison of electrocautery techniques and two insulated electrocautery blades. Pacing Clin Electrophysiol.2018;41:1593-1599.5. Ananwattanasuk T, Jame S, Bogun F, et al. Journal of Cardiovascular Electrophysiology. 2021.6. Hauser RG. The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. J Am Coll Cardiol. 2005;45:2022-2025.”
How it changed
Published 1 time since Oct 12, 2026.
- Version 2Oct 12, 2026Live now
AI-prepared Starting Map from live research.
- First published version.
Help improve it
The brief is open about what's uncertain. These are the specific gaps that new material would fill.
“What happens to the old pacemaker” has no evidence or firsthand experience yet
It's a synthesis for now. Evidence or experience would show whether it holds.
Open questions
What is the standard fate of an explanted pacemaker generator — clinical waste, manufacturer return, or analysis — and does this differ between routine battery depletion and advisory/recall replacements?
No answers yet
How long can reused leads be expected to function after a generator replacement, and how often does lead damage at replacement lead to a later extraction or reoperation?
No answers yet
Which patients are suitable for same-day discharge after replacement, and what selection criteria were used in the same-day-discharge study?
No answers yet
What does recovery actually feel like for patients — pain, wound care, time to return to normal activity — beyond the complication rates reported in registries?
No answers yet
Around this topic
Sylos connect: narrower topics report up to broader ones, so what's learned in one place shows up where it matters.